Milestones

1991

Urologix® is founded to develop manufacture and market medical devices for the treatment of urological disorders

1997

Urologix’ first product, the Targis® Cooled TUMT System, is approved by the FDA as a safe, durable, minimally invasive urological treatment alternative to drugs and surgery for the treatment of BPH

1999

Cruise software update including automated urethral feedback introduced

2000

Urologix purchases the Prostatron® Cooled TUMT System

Cruise II software update with enhanced rectal temperature feedback preventing unnecessary system shut downs introduced

Shorter treatment time (28.5 minutes) approved

2002

Targis Microwave Catheter [Short] introduced

2003

Targis Microwave Catheter [Long] introduced

Cooled ThermoCath® (CTC) [Standard] Microwave Catheter receives FDA approval

Rectal Thermal Unit Plus offered

2005

Urologix acquires three regional mobile BPH treatment service providers and launched its Urologix Mobile™ Service

Cooled ThermoCath (CTC) [Long] Microwave Catheter receives FDA approval

2006

The CoolWave® Control Unit enabling urologists to further customize benign prostatic hyperplasia treatment (BPH treatment) options for individual patients, is approved by the FDA and released to the marketplace

2007

Developed software upgrade for Targis System

Began CTC Advance® Microwave Catheter* development

2008

CTC Advance® Microwave Catheter receives FDA approval

5 Year results for Cooled ThermoTherapy™ presented at AUA, Continuing Results of a Multi-Center Trial of a New Generation Cooled TUMT for BPH

2009

5 Year Results of a Multi-Center Trial of a New Generation Cooled TUMT for BPH, Abstract 2122, presented at the 2009 AUA Annual Meeting in Chicago, IL

Effects of Urethral Temperature on Patient Outcomes for BPH with Cooled High Energy TUMT, Abstract 1944, presented at the 2009 AUA Annual Meeting in Chicago, IL

CTC Advance® Short Microwave Catheter released to the market to complete CTC Advance Microwave Catheter product line

2010

Urologix selected to present at the Geriatric Urological Society Annual Meeting; ‘Sexual Function after Cooled High Energy Transurethral Thermotherapy: Results of Patient Clinical Data up to 5 Years Post-Treatment’ and ‘Intra-Prostatic Temperatures and Necrosis during High Energy Cooled Microwave Treatment’

2011

5 Year Results of a Multi-Center Trial of a New Generation Cooled TUMT for BPH published in the May issue of the Journal of Urology. Authors include L. Mynderse, C. Roehrborn, A. Partin, G. Preminger, and E. Cote.

Acquires worldwide exclusive license to Prostiva® RF Therapy system Sep 6, 2011.

2013

Urologix becomes the licensed manufacturer for Prostiva® RF Therapy thereby acquiring manufacturing and regulatory responsibility for the product.